CoChat
Sign Up
Cited by 37Hair Growth and DisordersSperm and Testicular FunctionProstate Cancer Treatment and Research

Cause of Androgenic Alopecia: Crux of the Matter

Open access
Ustuner, Emin Tuncay·2013·Plastic and Reconstructive Surgery Global Open
DOI 10.1097/gox.0000000000000005PMC PMC4174066
Open this paper in CoChat — free account

Abstract

SUMMARY: What is wrong with the current understanding of etiopatho genesis of androgenic alopecia (AGA)? What is the most important question to ask to understand AGA? Why is that question skimped? Which findings are interpreted incorrectly? Is there anything that has not been discerned about AGA until today? What are the deceptive factors for investigators? Is it possible to snap the whole view uninterruptedly in one clear picture? Answers and an overview with fresh perspectives are provided.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/gox.0000000000000005

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Changes in hormones, particularly DHT, have been linked to some (but not all) occurrences of hair loss/baldness.

    “Given that changes in these hormones, particularly DHT, have been linked to some (but not all) occurrences of hair loss/baldness [62], the theory that creatine supplementation leads to hair loss / baldness gained some momentum and this potential link continues to be a common question / myth today.”

    From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [62]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. [1]Sawaya ME Price VH Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997 109 296 300 9284093
  2. [2]Schweikert HU Wilson JD Regulation of human hair growth by steroid hormones. I. Testerone metabolism in isolated hairs. J Clin Endocrinol Metab 1974 38 811 819 4823922
  3. [3]Dallob AL Sadick NS Unger W The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. J Clin Endocrinol Metab 1994 79 703 706 8077349
  4. [4]Hibberts NA Howell AE Randall VA Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol 1998 156 59 65 9496234
  5. [5]Kaufman KD Olsen EA Whiting D Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol 1998 39 4, Part 1 578 589 9777765
  6. [6]Kaufman KD Androgens and alopecia. Mol Cell Endocrinol 2002 198 89 95 12573818
  7. [7]Randall VA Androgens and human hair growth. Clin Endocrinol (Oxf) 1994 40 439 457 8187311
  8. [8]Stenn KS Paus R Controls of hair follicle cycling. Physiol Rev 2001 81 449 494 11152763
  9. [9]Ustuner ET Baldness may be caused by the weight of the scalp: gravity as a proposed mechanism for hair loss. Med Hypotheses 2008 71 505 514 18667278
  10. [10]Trüeb RM Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002 37 981 990 12213548
  11. [11]Levakov A Vucković N Dolai M Age-related skin changes. Med Pregl 2012 65 191 195 22730701
  12. [12]Caso G McNurlan MA Mileva I Peripheral fat loss and decline in adipogenesis in older humans. Metabolism 2013 62 337 340 22999012 PMC3531563
  13. [13]Xu XF De Pergola G Björntorp P Testosterone increases lipolysis and the number of beta-adrenoceptors in male rat adipocytes. Endocrinology 1991 128 379 382 1846106
  14. [15]Dieudonne MN Pecquery R Leneveu MC Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology 2000 141 649 656 10650946
  15. [16]Corbould A Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol 2007 192 585 594 17332526
  16. [17]Shen W Punyanitya M Silva AM Sexual dimorphism of adipose tissue distribution across the lifespan: a cross-sectional whole-body magnetic resonance imaging study. Nutr Metab (Lond) 2009 6 17 19371437 PMC2678136
  17. [18]Enzi G Gasparo M Biondetti PR Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986 44 739 746 3788827
  18. [19]Brincat MP Baron YM Galea R Estrogens and the skin. Climacteric 2005 8 110 123 16096167
  19. [20]Hall G Phillips TJ Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol 2005 53 555 568 quiz 569–572 16198774
  20. [22]Shu YY Maibach HI Estrogen and skin: therapeutic options. Am J Clin Dermatol 2011 12 297 311 21714580
  21. [23]Archer DF Postmenopausal skin and estrogen. Gynecol Endocrinol 2012 28 Suppl 2 2 6 22849791
  22. [24]Van Pelt RE Gozansky WS Hickner RC Acute modulation of adipose tissue lipolysis by intravenous estrogens. Obesity (Silver Spring) 2006 14 2163 2172 17189542 PMC2832608
  23. [25]Magerl M Tobin DJ Müller-Röver S Patterns of proliferation and apoptosis during murine hair follicle morphogenesis. J Invest Dermatol 2001 116 947 955 11407986
  24. [26]Paus R Müller-Röver S Van Der Veen C A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999 113 523 532 10504436
  25. [28]Xu X De Pergola G Björntorp P The effects of androgens on the regulation of lipolysis in adipose precursor cells. Endocrinology 1990 126 1229 1234 2153523
  26. [29]Singh R Artaza JN Taylor WE Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 2003 144 5081 5088 12960001
  27. [30]Glaser RL Dimitrakakis C Messenger AG Improvement in scalp hair growth in androgen-deficient women treated with testosterone: a questionnaire study. Br J Dermatol 2012 166 274 278 21967243 PMC3380548
  28. [31]Jaworsky C Kligman AM Murphy GF Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol 1992 127 239 246 1390168
  29. [32]Mahé YF Michelet JF Billoni N Androgenetic alopecia and microinflammation. Int J Dermatol 2000 39 576 584 10971723
  30. [33]Ellis JA Stebbing M Harrap SB Genetic analysis of male pattern baldness and the 5alpha-reductase genes. J Invest Dermatol 1998 110 849 853 9620288

Cited by

Sorted by citations

Authors
Ustuner, E. T.
Venue
Plastic and Reconstructive Surgery Global Open
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2013-10
Volume
1
Issue
7
Pages
e64
ISSN
2169-7574 (ISSN-L)
DOI
10.1097/gox.0000000000000005
PMC
PMC4174066
OpenAlex
W2089158372
Cited by
37
References
3
Citations by year
2026: 4 · 2025: 7 · 2024: 2 · 2023: 11 · 2022: 2 · 2021: 4 · 2020: 1 · 2019: 4 · 2018: 2
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Plastic & Reconstructive Surgery Global Open (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Urology › Hair Growth and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
Keywords
androgenetic alopecia, etiopathogenesis, hair loss, androgens

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review